Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Lars Stelter; Michael J. Evans; Achim A. Jungbluth; Pat Zanzonico; Gerd Ritter; Thomas Ku; Eric Rosenfeld; John S. Bomalaski; Lloyd Old; Steven M. Larson

doi:10.2967/jnumed.111.092973

Research ArticleBasic Science Investigations

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest ¹⁸F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Lars Stelter, Michael J. Evans, Achim A. Jungbluth, Pat Zanzonico, Gerd Ritter, Thomas Ku, Eric Rosenfeld, John S. Bomalaski, Lloyd Old and Steven M. Larson

Journal of Nuclear Medicine February 2012, 53 (2) 281-286; DOI: https://doi.org/10.2967/jnumed.111.092973

Lars Stelter

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Evans

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Achim A. Jungbluth

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pat Zanzonico

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerd Ritter

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Ku

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eric Rosenfeld

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John S. Bomalaski

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lloyd Old

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven M. Larson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 53, Issue 2

February 1, 2012

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest ¹⁸F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Lars Stelter, Michael J. Evans, Achim A. Jungbluth, Pat Zanzonico, Gerd Ritter, Thomas Ku, Eric Rosenfeld, John S. Bomalaski, Lloyd Old, Steven M. Larson

Journal of Nuclear Medicine Feb 2012, 53 (2) 281-286; DOI: 10.2967/jnumed.111.092973

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest ¹⁸F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Lars Stelter, Michael J. Evans, Achim A. Jungbluth, Pat Zanzonico, Gerd Ritter, Thomas Ku, Eric Rosenfeld, John S. Bomalaski, Lloyd Old, Steven M. Larson

Journal of Nuclear Medicine Feb 2012, 53 (2) 281-286; DOI: 10.2967/jnumed.111.092973

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

18F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging
Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase

Google Scholar

Main menu

User menu

Search

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest ¹⁸F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles